Literature DB >> 22222784

Comparative study on signal transduction in endothelial cells after anti-a/b and human leukocyte antigen antibody reaction: implication of accommodation.

Kenta Iwasaki1, Yuko Miwa, Haruko Ogawa, Satoko Yazaki, Masaki Iwamoto, Tadashi Furusawa, Akira Onishi, Takafumi Kuzuya, Masataka Haneda, Yoshihiko Watarai, Kazuharu Uchida, Takaaki Kobayashi.   

Abstract

BACKGROUND: Recent development of immunosuppressive therapy has provided a platform for clinical human leukocyte antigen (HLA)- and ABO-incompatible kidney transplantation. However, the prognosis seems to be different between the two. Accommodation, the condition of no injury even in the presence of antidonor antibody, is one of the key factors for successful transplantation with antidonor antibody. The purpose of this study was to compare signal transduction between anti-A/B and anti-HLA antibody reaction and to elucidate the mechanisms underlying accommodation.
METHODS: Blood type A- or B-transferase gene was transfected into human EA.hy926 endothelial cells. After cell sorting, A- or B-expressing cells at high levels were obtained. The effects of anti-HLA and anti-A/B antibody binding on complement-mediated cytotoxicity and signal transduction were examined.
RESULTS: Preincubation with anti-HLA antibodies only at low levels (<10% of saturation level) or anti-A/B antibodies at high levels (even at near saturation levels) for 24 hr resulted in resistance to complement-mediated cytotoxicity. Anti-A/B antibody ligation inactivated ERK1/2 pathway and increased complement regulatory proteins such as CD55 and CD59, whereas anti-HLA ligation activated PI3K/AKT pathway and increased cytoprotective genes such as hemeoxygenase-1 and ferritin H.
CONCLUSION: Complement inhibition by upregulation of CD55 and CD59 through ERK1/2 inactivation might play a substantial role in accommodation after ABO-incompatible transplantation, which could also explain the intriguing finding of C4d deposition in the graft without rejection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22222784     DOI: 10.1097/TP.0b013e3182424df3

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

Review 1.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

2.  Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Curr Transplant Rep       Date:  2015-05-24

3.  The suppressive effect on CD4 T cell alloresponse against endothelial HLA-DR via PD-L1 induced by anti-A/B ligation.

Authors:  K Iwasaki; H Hamana; H Kishi; T Yamamoto; T Hiramitsu; M Okad; T Tomosugi; A Takeda; S Narumi; Y Watarai; Y Miwa; M Okumura; Y Matsuoka; K Horimi; A Muraguchi; T Kobayash
Journal:  Clin Exp Immunol       Date:  2020-07-18       Impact factor: 4.330

Review 4.  HLA class I antibody-mediated endothelial and smooth muscle cell activation.

Authors:  Xiaohai Zhang; Nicole M Valenzuela; Elaine F Reed
Journal:  Curr Opin Organ Transplant       Date:  2012-08       Impact factor: 2.640

Review 5.  Current Perspectives in ABO-Incompatible Kidney Transplant.

Authors:  Federica Maritati; Claudia Bini; Vania Cuna; Francesco Tondolo; Sarah Lerario; Valeria Grandinetti; Marco Busutti; Valeria Corradetti; Gaetano La Manna; Giorgia Comai
Journal:  J Inflamm Res       Date:  2022-05-25

Review 6.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

Review 7.  The Complement System and Antibody-Mediated Transplant Rejection.

Authors:  Erik Stites; Moglie Le Quintrec; Joshua M Thurman
Journal:  J Immunol       Date:  2015-12-15       Impact factor: 5.422

Review 8.  MHC class I signaling: new functional perspectives for an old molecule.

Authors:  E W Tsai; E F Reed
Journal:  Tissue Antigens       Date:  2014-06

9.  Current progress in ABO-incompatible kidney transplantation.

Authors:  Tai Yeon Koo; Jaeseok Yang
Journal:  Kidney Res Clin Pract       Date:  2015-08-20

Review 10.  Transplant glomerulopathy: the interaction of HLA antibodies and endothelium.

Authors:  William Hanf; Claudine S Bonder; P Toby H Coates
Journal:  J Immunol Res       Date:  2014-03-09       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.